These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 4028017)
1. Relationship of queuine-lacking transfer RNA to the grade of malignancy in human leukemias and lymphomas. Emmerich B; Zubrod E; Weber H; Maubach PA; Kersten H; Kersten W Cancer Res; 1985 Sep; 45(9):4308-14. PubMed ID: 4028017 [No Abstract] [Full Text] [Related]
2. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers. Chen YL; Wu RT Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611 [TBL] [Abstract][Full Text] [Related]
3. Deficiency of queuine, a highly modified purine base, in transfer RNAs from primary and metastatic ovarian malignant tumors in women. Baranowski W; Dirheimer G; Jakowicki JA; Keith G Cancer Res; 1994 Aug; 54(16):4468-71. PubMed ID: 8044797 [TBL] [Abstract][Full Text] [Related]
4. The absence of the diet-derived 7-deazapurine, queuine in artificial liquid diets. Reyniers JP; Katze J; Farkas WR JPEN J Parenter Enteral Nutr; 1989; 13(5):542-4. PubMed ID: 2514297 [TBL] [Abstract][Full Text] [Related]
5. Defective transfer RNA-queuine modification in C3H10T1/2 murine fibroblasts transfected with oncogenic ras. Morgan CJ; Merrill FL; Trewyn RW Cancer Res; 1996 Feb; 56(3):594-8. PubMed ID: 8564977 [TBL] [Abstract][Full Text] [Related]
7. Relationship between a tumor promoter-induced decrease in queuine modification of transfer RNA in normal human cells and the expression of an altered cell phenotype. Elliott MS; Katze JR; Trewyn RW Cancer Res; 1984 Aug; 44(8):3215-9. PubMed ID: 6589040 [TBL] [Abstract][Full Text] [Related]
9. [Critical evaluation of the clinical use of new histopathological classifications of non-Hodgkin lymphomas]. Poccardi G; Urbano D; Torchio B; Giovanelli E; Sabbaa S; Neretto G Recenti Prog Med; 1982 Apr; 72(4):417-45. PubMed ID: 6755582 [No Abstract] [Full Text] [Related]
10. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062 [TBL] [Abstract][Full Text] [Related]
11. Cytokeratin expression in hematological neoplasms: a tissue microarray study on 866 lymphoma and leukemia cases. Adams H; Schmid P; Dirnhofer S; Tzankov A Pathol Res Pract; 2008; 204(8):569-73. PubMed ID: 18436389 [TBL] [Abstract][Full Text] [Related]
12. Inconclusive presence of adenovirus sequences in human leukemias and lymphomas. Fernandez-Soria V; Bornstein R; Forteza J; Parada C; Sanchez-Prieto R; Ramón y Cajal S Oncol Rep; 2002; 9(4):897-902. PubMed ID: 12066228 [TBL] [Abstract][Full Text] [Related]
13. In vitro bone marrow culture for colony forming units (CFU-C) in leukaemias and lymphomas. Kushwaha MR; Upadhyay GC; Bagchi M; Malik KA; Mehrotra RM Indian J Cancer; 1981 Mar; 18(1):13-9. PubMed ID: 7262902 [No Abstract] [Full Text] [Related]
14. Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance. Morra E; Lazzarino M; Orlandi E; Pagnucco G; Brusamolino E; Castello A; Inverardi D; Bernasconi C Haematologica; 1984; 69(1):15-29. PubMed ID: 6428991 [No Abstract] [Full Text] [Related]
15. TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation. Felgar RE; Macon WR; Kinney MC; Roberts S; Pasha T; Salhany KE Am J Pathol; 1997 Jun; 150(6):1893-900. PubMed ID: 9176382 [TBL] [Abstract][Full Text] [Related]
16. [Therapy of malignant lymphomas]. Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274 [TBL] [Abstract][Full Text] [Related]
17. Lymphoma of the ocular adnexa: A study of 353 cases. Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761 [TBL] [Abstract][Full Text] [Related]
18. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)]. Stacher A; Heinz R; Waldner R; Böhnel J Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765 [TBL] [Abstract][Full Text] [Related]
19. The need of adequate staging and aggressive therapy in non-Hodgkin's lymphomas. Report of 66 cases. Johansson RT; Joensuu H Strahlentherapie; 1983 Feb; 159(2):104-8. PubMed ID: 6836627 [No Abstract] [Full Text] [Related]
20. Variations in tRNA modifications, particularly of their queuine content in higher eukaryotes. Its relation to malignancy grading. Dirheimer G; Baranowski W; Keith G Biochimie; 1995; 77(1-2):99-103. PubMed ID: 7599283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]